Last Updated: 30 January 2025
Werlabs and Intel have announced a collaboration focused on tackling major healthcare challenges with innovative AI technology. They aim to equip medical professionals with advanced tools for preventive medicine, aiming to significantly improve health on a large scale.
“By deploying generative AI tools, we are equipping our medical doctors with new capabilities to deliver health insights and improve outcomes with unmatched scalability and quality assurance. We’re setting a bold goal: to reduce the prevalence of non-communicable diseases by 50% over time."
Henrik Forsberg, CEO of Werlabs AB
The core of the collaboration is the development of an AI-based decision support system aimed at improving the precision of general health assessments and facilitating the early detection of diseases.
“Our new accelerator kit is designed to empower cutting-edge developers of AI solutions. Healthcare stands to benefit greatly from this technology, and we’re excited to collaborate with Werlabs on this transformative mission to fight preventable diseases."
Johan Elfsson, Country Manager of Intel Sweden AB
Using AI, doctors will be able to offer highly personalized health recommendations, enhancing the effectiveness of preventive care and ultimately fostering better long-term health outcomes for individuals and communities.
Werlabs and Intel are bringing together their expertise in technology and healthcare to create the "Doctor AI Support" system, which is scheduled to launch in 2025. Constructed with Intel’s latest Gaudi 3 accelerator kit and Xeon 6 processors, the system is designed to be fast, cost-effective, and widely accessible, pushing the boundaries of what's possible in AI-driven healthcare solutions.
“Intel’s platform accelerates our AI development efforts, enabling faster innovation and expanding access to transformative tools. This collaboration isn't just about advancing technology—it’s a step toward a healthier future for everyone."
Henrik Forsberg, CEO of Werlabs AB
